CervoMed (CRVO) Non-Current Debt (2010 - 2014)
CervoMed (CRVO) posted Non-Current Debt of $715000.0 for Q2 2014, down 75.61% sequentially from $2.9 million in Q1 2014, and down 65.54% YoY from $2.1 million in Q2 2013.
CervoMed (CRVO) Non-Current Debt (2010 - 2014) Analysis & Trends
CervoMed has reported Non-Current Debt for 5 years, with the latest figure at $715000.0 in Q2 2014.
- Quarterly Non-Current Debt fell 65.54% year-over-year to $715000.0 in Q2 2014, while the trailing twelve-month figure through Jun 2014 was $715000.0 (down 65.54% YoY) and the FY2013 annual result came in at $1.7 million, down 58.37% from the prior year.
- Non-Current Debt declined to $715000.0 in Q2 2014 per CRVO's latest filing, from $2.9 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $4.2 million in Q1 2013 and troughed at $555000.0 in Q4 2011.
- A 5-year average of $2.1 million and a median of $2.1 million in 2013 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2012 and 2014: Non-Current Debt jumped 621.46% in 2012, then sank 65.54% in 2014.
- Over 5 years, Non-Current Debt stood at $625000.0 in 2010, then fell by 11.2% to $555000.0 in 2011, then surged by 621.46% to $4.0 million in 2012, then slumped by 58.37% to $1.7 million in 2013, then slumped by 57.11% to $715000.0 in 2014.
- According to Business Quant data, Non-Current Debt over the past three periods registered $715000.0, $2.9 million, and $1.7 million for Q2 2014, Q1 2014, and Q4 2013 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.19 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.58 Bn | 77.59 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.34 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.52 Bn | 51.38 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.04 Bn | 36.94 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.67 Bn | 27.36 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.27 Bn | 26.11 Bn | 358.27 Mn | 546.77 Mn |
| 8 | BioNTech SE | 27.14 Bn | 8.75 Bn | 668.28 Mn | 360.97 Mn |
| 9 | Royalty Pharma | 27.12 Bn | 26.28 Bn | - | 8.96 Bn |
| 10 | CervoMed | 26.50 Mn | 26.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 715,000.00 |
| Mar 31, 2014 | 2.93 Mn |
| Dec 31, 2013 | 1.67 Mn |
| Sep 30, 2013 | 2.58 Mn |
| Jun 30, 2013 | 2.08 Mn |
| Mar 31, 2013 | 4.22 Mn |
| Dec 31, 2012 | 4.00 Mn |
| Sep 30, 2012 | 3.43 Mn |
| Jun 30, 2012 | 2.75 Mn |
| Dec 31, 2011 | 555,000.00 |
| Sep 30, 2011 | 625,000.00 |
| Jun 30, 2011 | 625,000.00 |
| Dec 31, 2010 | 625,000.00 |